Page 16 - Avidity Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Octave Raises $52M in Series C Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesNew jerseyNew yorkSan franciscoSandeep acharyaCompany venturesHealth velocity capitalNovo holdingsCigna venturesAvidity partnersGreycroft partnersFelicis ventures

Hybrid behavioral healthcare company Octave scores $52M

The company will use the funds to release new offerings to providers and payers, expand its reach nationally in 2023 and establish a presence in all 50 states in 2024.

United statesNew yorkNew jerseySandeep acharyaSpring healthNovo holdingsHealth velocity capitalCompany venturesLyra healthAvidity partnersGreycroft partnersObvious venturesSan francisco based

Quanta Therapeutics Raises Over $50M in Series D Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

San franciscoUnited statesPerry nisenWs investment company wilson sonsiniQuanta therapeuticsAvidity partnersSofinnova investmentsVida venturesSurveyor capitalLongitude capitalWilson sonsiniInvestigational new drug applicationChief executive officer

Satellos Bioscience Closes $55M Financing to Support Development of its Lead Drug Candidate for Duchenne Muscular Dystrophy

Satellos Bioscience Closes $55M Financing to Support Development of its Lead Drug Candidate for Duchenne Muscular Dystrophy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomFrank gleesonChristina cameronMichael rudnickiJessica yinglingRyan mitchellBoard of directors the companyInsiders of the companyBusiness developmentSatellos bioscience incBloom burton securities incCommunications at satellos bioscience incNewsfile corpWall streetAvidity partners

Satellos Bioscience Inc : Satellos Bioscience Closes $55M Financing to Support Development of its Lead Drug Candidate for Duchenne Muscular Dystrophy

Toronto, Ontario (Newsfile Corp. - May 17, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the

United statesUnited kingdomMichael rudnickiGewinn nurRyan mitchellJessica yinglingFrank gleesonChristina cameronBusiness developmentBloom burton securities incSatellos bioscience incVenture exchangeInsiders of the companyBoard of directors the companyRegulatory services providerNewsfile corp